MotherToBaby

Medications and More during pregnancy and breastfeeding

Search

866.626.6847

Tralokinumab (Adbry ®)

Selected references.  

  • Deleuran M, et al. 2024. Systemic anti-inflammatory treatment of atopic dermatitis during conception, pregnancy and breastfeeding: Interdisciplinary expert consensus in Northern Europe. J Eur Acad Dermatol Venereol 38:31-41.
  • Product Information. 2021. ADBRY(TM) subcutaneous injection, tralokinumab-ldrm subcutaneous injection. LEO Pharma Inc. 
  • Stratigakis A, et al. 2023. A regression approach for assessing large molecular drug concentration in breast milk. Reprod Breed;3:199-207.  

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,000,000 with zero percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, HRSA, HHS, or the U.S. Government.